Loading...

ASPI ASP ISOTOPES INC Company Mergers 8-K Filing

SP S

SP

ASP ISOTOPES INC

(ASPI)

2025 8-K

Management Change

CEO Return Announcement

Acquisition Update

Quarterly Update

Quarterly Update Scheduled

Convertible Note Offering

IPO Announcement

QLE Notes Offering

Regulatory Engagement

Asset Acquisition

Stock Offering Announcement

Business Updates

Leadership Change

Purchase Order Announcement

Management Changes

Corporate Acquisition

Acquisition Update

Board Appointment

Shareholder Letter

Corporate Event Update

Joint Venture Announcement

Asset Acquisitions

Asset Acquisitions

Equity Offerings

Asset Acquisitions

Equity Offerings

Shareholder Updates

Equity Offerings

Merger of Equals

Asset Acquisitions

Webinar Announcement

Production Commencement

Production Start

Press Release Issued

Shareholder Update

Investor Access Event

Press Release Issued

Facility Commissioning

Annual Meeting Results

Nuclear Collaboration

Public Offering

Public Offering

Contract Announcement

Ytterbium-176 Enrichment

Equity Plan Amendment

Plant Completion

Public Offering

Convertible Note Offering

Entry into Material Definit...

Convertible Note Purchase A...

Departure of Director and A...

Annual Meeting of Stockholders

MOU for HALEU Supply

Release Agreement

Agreement for Share Purchase

Resignation and Appointment

Private Placement and Secur...

Regulation FD Disclosure

Prepayment from Customer

Compliance with Minimum Bid...

Regulation FD Disclosure

Material Definitive Agreement

External Links:

ASP Isotopes Inc. has extended the deadline for completing its acquisition of Renergen Limited to January 30, 2026, originally set for November 28, 2025, allowing more time for regulatory approvals and necessary consents. The acquisition offer involves Renergen shareholders receiving 0.09196 ASP Isotopes shares per share held.

AI Assistant

ASP ISOTOPES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.